The DOI matches its Crossref record; 52 of the 56 references it cites were found in a registry or an index.
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
Open accessAbstract
Glucocorticoid-induced bone disease is characterized by decreased bone formation and in situ death of isolated segments of bone (osteonecrosis) suggesting that glucocorticoid excess, the third most common cause of osteoporosis, may affect the birth or death rate of bone cells, thus reducing their numbers. To test this hypothesis, we administered prednisolone to 7-mo-old mice for 27 d and found decreased bone density, serum osteocalcin, and cancellous bone area along with trabecular narrowing. These changes were accompanied by diminished bone formation and turnover, as determined by histomorphometric analysis of tetracycline-labeled vertebrae, and impaired osteoblastogenesis and osteoclastogenesis, as determined by ex vivo bone marrow cell cultures. In addition, the mice exhibited a threefold increase in osteoblast apoptosis in vertebrae and showed apoptosis in 28% of the osteocytes in metaphyseal cortical bone. As in mice, an increase in osteoblast and osteocyte apoptosis was documented in patients with glucocorticoid-induced osteoporosis. Decreased production of osteoclasts explains the reduction in bone turnover, whereas decreased production and apoptosis of osteoblasts would account for the decline in bone formation and trabecular width. Furthermore, accumulation of apoptotic osteocytes may contribute to osteonecrosis. These findings provide evidence that glucocorticoid-induced bone disease arises from changes in the numbers of bone cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A high level of glucocorticoid in smokers alters bone metabolism and decreases bone mass either directly by changing the osteoblast and osteoclast activities or indirectly by altering the gastrointestinal absorption and renal reabsorption of calcium [39–42].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [39]
Experimental — accuracy not yet measuredIn the citing paper
“In mice, BMD loss with prednisolone was associated with decreased osteocalcin and decreased bone formation, with no histological or biochemical evidence for increased bone resorption (251).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [251]
In the citing paper
“bone marrow harvested from mice treated with prednisolone showed reduced osteoclastogenic potential (251).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [251]
In the citing paper
“One important component of glucocorticoid biology that is lacking in most cell culture models is the marked depletion of osteoblast numbers in animals treated with glucocorticoids (251).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [251]
In the citing paper
“Bone marrow harvested from mice treated with prednisolone was shown to have markedly reduced osteoblastogenic capacity (251).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [251]
In the citing paper
“Glucocorticoids can also inhibit osteoblast differentiation (249 -251), osteoblast attachment to bone matrix (252), and osteoblast production of IGF-I (253).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [251]
In the citing paper
“The prednisolonerelated increase in bone volume in rats, confirmed in a study described immediately below (262), is not consistent with histological data from patients with glucocorticoid-induced osteoporosis (194) and is a recognized limitation of the model (251).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [251]
In the citing paper
“Glucocorticoids decrease BMD in rats (262, 263), mice (251), and minipigs (264).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [251]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Self-citationBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citationThe Fire of Life: An Introduction to Animal Energetics
Kleiber, M. (1975) · Medical Entomology and Zoology · Cited by 2,529
PARFITT, A. M., Mathews, C. H. E., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,542
Self-citationIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440
Self-citationIdiopathic bone necrosis of the femoral head. Early diagnosis and treatment
Ficat, R. P. (1985) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.67b1.3155745 · Cited by 1,339
Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001
Self-citationNontraumatic Necrosis of Bone (Osteonecrosis)
Desforges, J. F., & Mankin, H. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262206 · Cited by 965
Cushing, H. (1964) · Journal of neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 849
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.793 · Cited by 578 · cited 3×
“In addition, TUNEL has been used with DNA fragmentation and immunohistochemical studies to demonstrate apoptosis of osteoblastic cells and osteoblasts both in vitro and in vivo (8, 20).”
BackgroundMethodSelf-citationBursch, W., Paffe, S., Putz, B., Barthel, G., & Schulte‐Hermann, R. (1990) · Carcinogenesis · doi:10.1093/carcin/11.5.847 · Cited by 444
The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
Tomkinson, A., REEVE, J., Shaw, R. W., & Noble, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4200 · Cited by 417
Function of osteocytes in bone
Aarden, E. M., Nijweide, P. J., & Burger, E. H. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550304 · Cited by 410
Bellows, C. G., Aubin, J. E., & Heersche, J. N. M. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90100-e · Cited by 396
Jilka, R. L., Weinstein, R. S., Takahashi, K., PARFITT, A. M., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118600 · Cited by 339
Self-citationPerspectives bone histomorphometry in glucocorticoid-induced osteoporosis
Dempster, D. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040202 · Cited by 319
BELLOWS, C. G., AUBIN, J. E., & HEERSCHE, J. N. M. (1987) · Endocrinology · doi:10.1210/endo-121-6-1985 · Cited by 306
Newman, E., Turner, A. S., & Wark, J. D. (1995) · Bone · doi:10.1016/s8756-3282(95)80121-9 · Cited by 302
Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis
Bressot, C., Meunier, P. J., Chapuy, M. C., Lejeune, E., Edouard, C. M., & Darby, A. J. (1979) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(79)90024-9 · Cited by 297
Felson, D. T., & Anderson, J. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92870-4 · Cited by 269
Parfitt, A. M., Villanueva, A. R., Foldes, J., & Rao, D. S. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100319 · Cited by 231
Self-citationIdentification of apoptotic changes in osteocytes in normal and pathological human bone
Noble, B. S., Stevens, H., Loveridge, N., & Reeve, J. (1997) · Bone · doi:10.1016/s8756-3282(96)00365-1 · Cited by 230
Deramaudt, B. M. J. ‐., Braunstein, S. E., Rémy, P., & Abraham, N. G. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980101)68:1 · Cited by 215
Frost, H. M. (1960) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-196042010-00011 · Cited by 193
Diminished Rates of Bone Formation in Normal Black Adults
Weinstein, R. S., & Bell, N. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192603 · Cited by 191
Self-citationNewman, E. (1995) · Bone · doi:10.1016/8756-3282(95)00026-a · Cited by 191
Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis
Dempster, D., Moonga, B., Stein, L., Horbert, W., & Antakly, T. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1540397 · Cited by 180
PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS
Reid, I. R. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb03730.x · Cited by 174
Lian, J. B., Shalhoub, V., Aslam, F., Frenkel, B., Green, J., Hamrah, M., Stein, G. S., & Stein, J. L. (1997) · Endocrinology · doi:10.1210/endo.138.5.5117 · Cited by 154 · cited 2×
“inhibit differentiation in a murine osteoblastic cell line (34).”
BackgroundGLUCOCORTICOID-INDUCED OSTEOPOROSIS
Lukert, B. P., & Raisz, L. G. (1994) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00353-7 · Cited by 153
Drug dosage in laboratory animals: A handbook
(1966) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(66)80455-8 · Cited by 148
Kawai, K., TAMAKI, A., & Hirohata, K. (1985) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198567050-00010 · Cited by 143
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5359 · Cited by 126
Self-citationCharacterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow
Falla, N., Van, V., Bierkens, J., Borremans, B., Schoeters, G. E. R., & Gorp, U. V. (1993) · Blood · doi:10.1182/blood.v82.12.3580.3580 · Cited by 98
Osteocyte death and hip fracture
Dunstan, C. R., Somers, N. M., & Evans, R. A. (1993) · Calcified Tissue International · doi:10.1007/bf01673417 · Cited by 96
Stanton, B. A., Giebisch, G., Klein-Robbenhaar, G., Wade, J. B., & DeFronzo, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111832 · Cited by 80
Effects of continuous glucocorticoid infusion on bone metabolism in the rat.
King, C. S., Weir, E. C., Gundberg, C. W., Fox, J., & Insogna, K. L. (1996) · Calcified Tissue International · doi:10.1007/s002239900107 · Cited by 68
Short-term effects of corticosteroids on trabecular bone remodeling in old ewes
Chavassieux, P., Buffet, A., Vergnaud, P., Garnero, P., & Meunier, P. J. (1997) · Bone · doi:10.1016/s8756-3282(97)00016-1 · Cited by 67
Skeletal response to corticosteroid deficiency and excess in growing male rats
Li, M., Shen, Y., Halloran, B. P., Baumann, B. D., Miller, K. G., & Wronski, T. J. (1996) · Bone · doi:10.1016/8756-3282(96)00170-6 · Cited by 66
Kinetics and Dynamics of Prednisolone*
Frey, F. J. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-4-453 · Cited by 64
Quarles, L. D. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.1.e136 · Cited by 54
FROST, H. M. (1960) · PubMed · Cited by 50
92238400 Increased osteoclast development after estrogen loss: Mediation by interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1993) · Maturitas · doi:10.1016/0378-5122(93)90156-c · Cited by 48
Self-citationConaway, H. H., Grigorie, D., & Lerner, U. H. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111008 · Cited by 42
Grardel, B., Sutter, B., Flautre, B., Viguier, É., Lavaste, F., & Hardouin, P. (1994) · Osteoporosis International · doi:10.1007/bf01623240 · Cited by 36
A Quantitative Histological Study of Rib from 18 Patients Treated with Adrenal Cortical Steroids
Klein, M., Villanueva, A. R., & Frost, H. M. (1965) · Acta Orthopaedica Scandinavica · doi:10.3109/17453676508989351 · Cited by 33
Effect of antiandrogens casodex and epitestosterone on bone composition in mice
Broulik, P. D., & Stárka, L. (1997) · Bone · doi:10.1016/s8756-3282(97)00012-4 · Cited by 26
Idiopathic Necrosis of the Femoral Head
Wagner, H., & Zeiler, G. (1981) · Progress in orthopaedic surgery · doi:10.1007/978-3-642-68049-6_8 · Cited by 20
Comparison between bone density and bone strength in glucocorticoid-treated aged ewes
Deloffre, P., Hans, D., Rumelhart, C., Mitton, D., Tsouderos, Y., & Meunier, P. J. (1995) · Bone · doi:10.1016/8756-3282(95)00319-9 · Cited by 20
Cline, M. J. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411282912211 · Cited by 19
Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow
Falla, N., Van, V., Bierkens, J., et al. (1993) · Blood · doi:10.1182/blood.v82.12.3580.bloodjournal82123580 · Cited by 10
Glucocorticoid-induced osteoporosis
Yeap, S. S., & Hosking, D. J. (1995) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199506000-00008 · Cited by 10
Flagged first, then by citations
4 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- [11]11. Cope, C.L. 1972. The synthetic analogues. In Adrenal Steroids and Dis- ease. Lippincott, Philadelphia, PA. 488-491.
- [17]17. Owen, M. 1985. Lineage of osteogenic cells and their relationship to the stromal system. In Bone and Mineral Research. Volume 3. W.A. Peck, editor. Elsevier, Amsterdam. 1-25.
- [42]42. Manolagas, S.C., R.L. Jilka, T. Bellido, C.A. O'Brien, and A.M. Parfitt. 1996. Interleukin-6-type cytokines and their receptors. In Principles of Bone Bi- ology. J.P. Bilezikian, L.G. Raisz, and G.A. Rodan, editors. Academic Press, San Diego, CA. 701-713.
Cited by
Sorted by citations
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,639
“loss of estrogen, or glucocorticoid excess (130), could increase”
BackgroundSelf-citationMechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Immune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Hadjidakis, D., & Androulakis, I. I. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.035 · Cited by 1,531
Metadata
- Authors
- Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-07-15
- Volume
- 102
- Issue
- 2
- Pages
- 274-282
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508885
- OpenAlex
- W2002315967
- Cited by
- 1,753
- References
- 56
- Citations by year
- 2026: 25 · 2025: 35 · 2024: 44 · 2023: 63 · 2022: 55 · 2021: 69 · 2020: 65 · 2019: 60 · 2018: 59 · 2017: 63 · 2016: 72 · 2015: 59 · 2014: 77 · 2013: 70 · 2012: 74
- FWCI
- 15.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5r01ar043003-05)
- National Institute on Aging (P01 AG-13918, P01AG013918)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR43003)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoid-induced osteoporosis, osteoblastogenesis, osteoblast apoptosis, osteocyte apoptosis, prednisolone, avascular necrosis, bone formation, bone turnover, osteoclastogenesis, trabecular bone, bone mineral density, osteocalcin
- MeSH terms
- Adult, Animals, Bone and Bones, Bone Marrow Cells, Bone Resorption, Cells, Cultured, Female, Glucocorticoids, Humans, Male, Osteoblasts, Osteocytes, Osteoporosis, Prednisolone, Spine, Bone Density, Apoptosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
